drugset / Trial / NCT00117338

A Study of an Intravenous Drug in Pediatric Patients With Acute Asthma (0476-301)

NCT00117338

Phase 3 Completed 276 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will attempt to find out if the addition of an intravenous form of a drug that is already used for treating asthma in children will help resolve asthma attacks faster than using the current standard care alone.

Timeline

Start
2005-07
Primary completion
2008-03
Completion
2008-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Montelukast Other / unclassified 5.25 mg Intravenous

Indications